|
|
||||||||
ORIGINAL ARTICLES |
Section of Nephrology, University of Manitoba, Winnipeg, Manitoba, Canada
Correspondence to: A. Fine, Section of Nephrology, St. Boniface General
Hospital, 409 Tache Avenue, Winnipeg, Manitoba R2H 2A6
Canada.
dr_adrian_fine{at}yahoo.ca
Background: We previously reported a very high
incidence of calciphylaxis, mainly in peritoneal dialysis (PD) patients.
Although we identified several risk factors for the condition, including PD,
we were unable to identify why our particular unit had such a high frequency
of the condition and a reliable treatment.
Objectives: To assess the apparent changing frequency
of the condition and the response to therapy, and to attempt to determine
putative factors that might explain our uniquely high incidence of
calciphylaxis.
Methods: A prospective clinical record was kept on all
patients that developed calciphylaxis in our center [both PD and hemodialysis
(HD) units] between 1998 and 2006.
Results: Of the 59 patients that developed
calciphylaxis, 54 were on PD, 4 were on HD, and 1 was in predialysis. In the
PD population, the mean yearly incidence from 1998 to 2003 was 4.5/100
patient-years, falling to 1.3/100 patient-years in 2004-2006. The percent of
patients not taking calcium salts fell during this time period. Conversion to
HD led to marked early improvement. A marked discrepancy between the levels of
ionized calcium (routinely used in our center) and corrected serum calcium was
found, with most cases of hypercalcemia (corrected) being missed by using
ionized values.
Conclusions: The incidence of calciphylaxis is falling
dramatically. This may be related partially to reduction in usage of calcium
salts. Conversion to HD is beneficial. Our uniquely high incidence of
calciphylaxis may be related to our use of ionized calcium levels to monitor
these patients.
KEY WORDS: Calciphylaxis; ionized calcium; calcium salts.
Received 15 May 2007; accepted 23 October 2007.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |